Milk and Milk-produce to Counteract the Loss of Muscle Mass and Function in Exercising Older Adults. — PRO  

Sarcopenia Clinical Trial

Official title: Milk and Milk-produce to Counteract the Loss of Muscle Mass and Function in Exercising Older Adults.

Status Completed

Clinical Trial Summary

This project evaluates the use of different types of proteins from various food sources after an exercise session, on muscle mass and physical capacity in aged sarcopenic men (who have low muscle mass). Specifically, researchers want to:

• Examine the efficiency of protein intake after exercise on muscle mass and physical abilities;

• Examine the impact of exercise and proteins on blood lipids (LDL cholesterol, HDL cholesterol, total cholesterol and triglycerides);

• Examine the impact of exercise and proteins on liver enzymes;

• Examine the impact of exercise and proteins on a hormone that controls hunger;

• Evaluate the program's impact on the ability of the body to produce energy.

All participants are exercising (resistance training) and ingest one of the 3 different sources of proteins, immediately after training:

• Milk proteins (from milk beverage)

• Essential amino acids (added to a soya beverage)

• No protein (rice beverage - control group)

Our hypothesis is that proteins from milk will induce a gain in muscle mass and physical function equivalent to the essential amino acids (EAA). We anticipate that both milk proteins and EAA will be both superior to control group.

This would represent an interesting finding since milk is more accessible, palatable and cheaper than essential amino acids commercial mix.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Sarcopenia

• NCT number: NCT01883674
• Study type: Interventional
• Source: Université de Sherbrooke
• Status: Completed
• Phase: N/A
• Start date: May 2012
• Completion date: December 2014